ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)

HKG:1541 Statistics

Total Valuation

HKG:1541 has a market cap or net worth of HKD 1.32 billion. The enterprise value is 437.76 million.

Market Cap	1.32B
Enterprise Value	437.76M

Important Dates

The next estimated earnings date is Tuesday, June 2, 2026.

Earnings Date	Jun 2, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1541 has 431.51 million shares outstanding. The number of shares has increased by 9.36% in one year.

Current Share Class	420.48M
Shares Outstanding	431.51M
Shares Change (YoY)	+9.36%
Shares Change (QoQ)	+2.52%
Owned by Insiders (%)	16.33%
Owned by Institutions (%)	17.36%
Float	278.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.67
PB Ratio	1.50
P/TBV Ratio	1.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.80
EV / Sales	2.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.93

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.29.

Current Ratio	3.83
Quick Ratio	3.74
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-1.12
Interest Coverage	-42.05

Financial Efficiency

Return on equity (ROE) is -29.87% and return on invested capital (ROIC) is -15.21%.

Return on Equity (ROE)	-29.87%
Return on Assets (ROA)	-13.80%
Return on Invested Capital (ROIC)	-15.21%
Return on Capital Employed (ROCE)	-27.11%
Weighted Average Cost of Capital (WACC)	5.76%
Revenue Per Employee	850,000
Profits Per Employee	-1.20M
Employee Count	202
Asset Turnover	0.15
Inventory Turnover	0.04

Taxes

In the past 12 months, HKG:1541 has paid 32,271 in taxes.

Income Tax	32,271
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.60% in the last 52 weeks. The beta is 0.41, so HKG:1541's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-71.60%
50-Day Moving Average	4.57
200-Day Moving Average	7.43
Relative Strength Index (RSI)	23.57
Average Volume (20 Days)	1,364,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1541 had revenue of HKD 171.70 million and -243.24 million in losses. Loss per share was -0.59.

Revenue	171.70M
Gross Profit	170.46M
Operating Income	-248.20M
Pretax Income	-243.99M
Net Income	-243.24M
EBITDA	-238.93M
EBIT	-248.20M
Loss Per Share	-0.59

Balance Sheet

The company has 1.13 billion in cash and 253.75 million in debt, with a net cash position of 876.89 million or 2.03 per share.

Cash & Cash Equivalents	1.13B
Total Debt	253.75M
Net Cash	876.89M
Net Cash Per Share	2.03
Equity (Book Value)	879.27M
Book Value Per Share	2.04
Working Capital	869.26M

Cash Flow

In the last 12 months, operating cash flow was -225.44 million and capital expenditures -1.46 million, giving a free cash flow of -226.90 million.

Operating Cash Flow	-225.44M
Capital Expenditures	-1.46M
Depreciation & Amortization	11.88M
Net Borrowing	n/a
Free Cash Flow	-226.90M
FCF Per Share	-0.53

Margins

Gross margin is 99.28%, with operating and profit margins of -144.55% and -141.66%.

Gross Margin	99.28%
Operating Margin	-144.55%
Pretax Margin	-142.10%
Profit Margin	-141.66%
EBITDA Margin	-139.16%
EBIT Margin	-144.55%
FCF Margin	n/a

Dividends & Yields

HKG:1541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.36%
Shareholder Yield	-9.36%
Earnings Yield	-18.48%
FCF Yield	-17.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1541 has an Altman Z-Score of 5.14 and a Piotroski F-Score of 2.

Altman Z-Score	5.14
Piotroski F-Score	2